COMPARATIVE EVALUATION OF FIRST ORDER, ABSORBANCE RATIO AND BIVARIATE SPECTROPHOTOMETRIC METHODS FOR DETERMINATION OF ATOVAQUONE AND PROGUANIL IN PHARMACEUTICAL FORMULATION MALARONE®

Authors

  • Vijay D. Chavada Gujarat University
  • Nejal M. Bhatt Gujarat University
  • Mallika Sanyal Gujarat University
  • Pranav S. Shrivastav Department of Chemistry, School of Sciences, Gujarat University, Navrangpura, Ahmedabad 380009

Keywords:

Atovaquone, Proguanil hydrochloride, Derivative spectrophotometry, Absorbance-ratio method, Bivariate Method, Malarone

Abstract

Objective: Three simple, rapid, accurate and precise spectrophotometric methods have been developed for the simultaneous estimation of atovaquone and proguanil hydrochloride in pharmaceutical preparations.

Methods: The determination of drugs was carried out using the first order derivative, absorbance-ratio and bivariate spectrophotometric methods. The methods were validated for their linearity, accuracy and precision, recovery and ruggedness according to the ICH guidelines.

Results: The linearity was established in the concentration range of 1.0-10 µg/ml for atovaquone and 0.5-8.0 µg/ml for proguanil hydrochloride by all three methods. The limit of detection (LOD) and the limit of quantitation (LOQ) of the methods varied from 0.252 to 0.270 µg/ml and 0.764 to 0.825 µg/ml for atovaquone and 0.119 to 0.156 µg/ml and 0.361 to 472 µg/ml for proguanil hydrochloride respectively. The intra-and inter-batch accuracy (% recovery) and precision (% RSD) ranged from 99.16 to 101.05 % and 0.603 to 1.048 for atovaquone and 99.74 to 101.12 % and 0.593 to 1.001 for proguanil respectively.

Conclusion: The proposed methods were applied to a pharmaceutical formulation with acceptable accuracy and precision without any interference from commonly used excipients and additives. The results show that all three methods are comparable, cost effective and rapid and thus can be readily used in quality control labs for routine analysis of these drugs.

 

Downloads

Download data is not yet available.

References

Fry M, Beesley JE. Mitochondria of mammalian Plasmodium spp. Parasitology 1991;102:17-26.

Hudson AT, Dickins M, Ginger CD, Gutteridge WE, Holdich T, Hutchinson DB, et al. 566C80: A potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 1991;17:427-35.

Canfield CJ, Pudney M, Gutteridge WE. Interactions of atovaquone with other antimalarial drugs against Plasmodium Falciparum in vitro. Exp Parasitol 1995;80:373-81.

Birkett DJ, Rees D, Andersson T, Gonzalez FJ, Miners JO, Veronese ME. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP 3A isoforms as well as by S-mephenytoin hydroxylase. Braz J Clin Pharmacol 1994;37:413-20.

McKeage K, Scott LJ. Atovaquone/proguanil-A review of its use for the prophylaxis of Plasmodium Falciparum malaria. Drugs 2003;63:597-623.

Nicosia V, Colombo G, Cosentino M, Di Matteo S, Mika F, De Sanctis S, et al. Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis. J Ther Clin Risk Management 2008;4:1105-10.

Wahajuddin W, Raju KSR, Taneja I. Bioanalysis of antimalarials using liquid chromatography. Trends Anal Chem 2013;42:186-204.

Michelitsch A, Rittmannsberger A. Determination of atovaquone in tablets by differential pulse polarography. Pharmazie 2002;57:465-7.

Chou CC, Brown MP, Merritt KA. Capillary zone electrophoresis for the determination of atovaquone in serum. J Chromatogr B 2000;742:441-5.

Moody RR, Taylor RB. An HPLC assay for the determination of proguanil hydrochloride in tablets. Int J Pharm 1980;7:177-8.

Calatayud JM, Falcóa PC, Martía MCP. Spectrofluorimetric determination of proguanil in biological fluids. Anal Lett 1986;19:1311-21.

Taylor RB, Reid RG, Low AS. Analysis of proguanil and its metabolites by application of the sweeping technique in micellar electrokinetic chromatography. J Chromatogr A 2001;916:201–6.

Paci A, Caire-Maurisier AM, Rieutord A, Brion F, Clair P. Dual-mode gradient HPLC procedure for the simultaneous determination of chloroquine and proguanil. J Pharm Biomed Anal 2002;27:1-7.

Lejeune D, Souletie I, Houzé S, Le bricon T, Le Bras J, Gourmel B, et al. Simultaneous determination of monodes ethylchloroquine, chloroquine, cycloguanil and proguanil on dried blood spots by reverse-phase liquid chromatography. J Pharm Biomed Anal 2007;43:1106-15.

Leveque NL, Charman WN, Chiu FCK. Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography–mass spectrometry. J Chromatogr B 2006;830:314-21.

Idowu AR. Spectrofluorimetric determination of proguanil in biological fluids. Anal Chim Acta 1987;199:215-20.

Stagg H. Determination of N-(p-chloro)-N-isopropyl biguanide. J Pharmacol Pharmacother 1947;1:391-4.

Gallo U, Nastasi A, Novocic L. Determination of proguanil in non-aqueous solvents. Bull-Chim Farm 1955;94:85-9.

Smith CC, Ihrig J, Menne T. Anti-malarial activity and metabolism of biguanides I.: metabolism of chloroguanide triazine in rhesus monkeys and man. Am J Trop Med Hyg 1961;10:694-703.

Adewuyi GO, Olubomehin O, Ayanniyi AW. High performance liquid chromatographic determination of proguanil after derivatisation with sodium benzoxazole-2-sulphonate. Afr J Biotechnol 2010;9:900-5.

Smarzewska S, Skrzypek S, Ciesielski W. Voltammetric determination of proguanil in malarone and spiked urine with a renewable silver amalgam film electrode. Electroanal 2012;24:1966-72.

Bergqvist Y, Hopstadius C. Simultaneous separation of atovaquone, proguanil and its metabolites on a mixed mode high-performance liquid chromatographic column. J Chromatogr B 2000;741:189-93.

Lindegårdh N, Blessborn D, Bergqvist Y. Simultaneous quantitation of the highly lipophilic atovaquone and hydrophilic strong basic proguanil and its metabolites using a new mixed-mode SPE approach and steep-gradient LC. J Chromatogr Sci 2005;43:259-66.

International Conference on Harmonization (ICH). Validation of Analytical Procedures: Text and Methodology Q2 (R1); 2005.

El-Sayed AY, El-Salem NA. Recent developments of derivative spectrophotometry and their analytical applications. Anal Sci 2005;21:595-614.

Rojas FS, Ojeda CB. Recent development in derivative ultraviolet/visible absorption spectrophotometry: 2004-2008. A review. Anal Chim Acta 2009;635:22-44.

Erk N. Quantitative analysis of chlorpheniramine maleate and phenylephrine hydrochloride in nasal drops by differential-derivative spectrophotometric, zero-crossing first derivative UV spectrophotometric and absorbance ratio methods. J Pharm Biomed Anal 2000;23:1023-31.

Davidson AG, Beckett AH, Stenlake JB. Practical Pharmaceutical Chemistry. 4th edition. CBS Publishers and Distributor: New Delhi, India; 2001.

López-de-Alba PL, López-Martínez L, Wróbel-Kaczmarczyk K, Wróbel-Zasada K, Amador-Hernández J. The resolution of dye binary mixtures by bivariate calibration using spectrophotometric data. Anal Lett 1996;29:487-503.

Massart DL, Vandeginste BGM, Deming SN, Michotte Y, Kaufman L. Chemometrics: A Textbook, Elsevier: Amsterdam, Netherland; 1988.

Published

01-09-2015

How to Cite

Chavada, V. D., N. M. Bhatt, M. Sanyal, and P. S. Shrivastav. “COMPARATIVE EVALUATION OF FIRST ORDER, ABSORBANCE RATIO AND BIVARIATE SPECTROPHOTOMETRIC METHODS FOR DETERMINATION OF ATOVAQUONE AND PROGUANIL IN PHARMACEUTICAL FORMULATION MALARONE®”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 9, Sept. 2015, pp. 165-71, https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/7296.

Issue

Section

Original Article(s)